Contact
DMCA
Privacy
Robuta
https://www.pharmaceutical-technology.com/data-insights/amantadine-hydrochloride-shinkei-therapeutics-traumatic-brain-injury-likelihood-of-approval/
Amantadine hydrochloride by Shinkei Therapeutics for Traumatic Brain Injury: Likelihood of Approval
Amantadine hydrochloride is under clinical development by Shinkei Therapeutics and currently in Phase II for Traumatic Brain Injury.
traumatic brain injury
amantadine hydrochloride
shinkei
therapeutics
likelihood